Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial

• Sylvie Chevret,
• Lila Bouadma,
• Claire Dupuis,
• Charles Burdet,
• Jean‑Francois Timsit,
• the COVIDICUS RCT group

Affiliations

Sylvie Chevret

ECSTRRA, UMR 1153, Saint Louis Hospital, University Paris Cité

Lila Bouadma

Medical and Infectious Diseases ICU, APHP Bichat Hospital

Claire Dupuis

Université Paris Cité, IAME, INSERM, UMR 1137

Charles Burdet

Université Paris Cité, IAME, INSERM, UMR 1137

Jean‑Francois Timsit

Medical and Infectious Diseases ICU, APHP Bichat Hospital

the COVIDICUS RCT group